Lincoln Pharmaceuticals Ltd
Company Profile
Business description
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
Contact
Science City Road
Lincoln House
Behind Satyam Complex
Sola
AhmedabadGJ380060
INDT: +91 7941078000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
1,919
Stocks News & Analysis
stocks
What next for the largest company on the ASX?
stocks
Ask the analyst: Are IDP Education's woes temporary?
stocks
Is it time to buy the Magnificent Seven?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,013.30 | 10.70 | 0.13% |
CAC 40 | 8,028.28 | 90.07 | 1.13% |
DAX 40 | 22,986.82 | 419.68 | 1.86% |
Dow JONES (US) | 41,488.19 | 674.62 | 1.65% |
FTSE 100 | 8,632.33 | 89.77 | 1.05% |
HKSE | 23,959.98 | 359.67 | 1.52% |
NASDAQ | 17,754.09 | 451.07 | 2.61% |
Nikkei 225 | 37,053.10 | 234.01 | 0.64% |
NZX 50 Index | 12,266.25 | 57.20 | 0.47% |
S&P 500 | 5,638.94 | 117.42 | 2.13% |
S&P/ASX 200 | 7,789.70 | 3.50 | 0.04% |
SSE Composite Index | 3,419.56 | 60.83 | 1.81% |